Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

[ad_1] SAN DIEGO and ZUG, Switzerland, Nov. 3, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced the United Kingdom’s Medicines and Healthcare Products Regulatory…

Don’t rely on temperature screening products for detection of coronavirus (COVID-19), says MHRA

[ad_1] The Agency is telling manufacturers and suppliers of thermal cameras that they should not make claims which directly relate to COVID-19 diagnosis, and is reminding businesses to follow Government…

MHRA recalls all pholcodine-containing medicines from UK – Latest Pharmacy News | Business | Magazine – Pharmacy Business

[ad_1] MHRA recalls all pholcodine-containing medicines from UK – Latest Pharmacy News | Business | Magazine – Pharmacy Business Privacy Preferences [ad_2] Source link